This report contains market size and forecasts of Single Nucleotide Polymorphism (SNP) Genotyping in Global, including the following market information:
Global Single Nucleotide Polymorphism (SNP) Genotyping Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Single Nucleotide Polymorphism (SNP) Genotyping market was valued at 14360 million in 2020 and is projected to reach US$ 29980 million by 2027, at a CAGR of 20.2% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Single Nucleotide Polymorphism (SNP) Genotyping companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Single Nucleotide Polymorphism (SNP) Genotyping Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Single Nucleotide Polymorphism (SNP) Genotyping Market Segment Percentages, By Type, 2020 (%)
Transversion
Transition
China Single Nucleotide Polymorphism (SNP) Genotyping Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Single Nucleotide Polymorphism (SNP) Genotyping Market Segment Percentages, By Application, 2020 (%)
Diagnostics
Animal
Plant
Research
Others
Global Single Nucleotide Polymorphism (SNP) Genotyping Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Single Nucleotide Polymorphism (SNP) Genotyping Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Single Nucleotide Polymorphism (SNP) Genotyping Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Single Nucleotide Polymorphism (SNP) Genotyping Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Illumina
Affymetrix
Applied Biosystems
Agilent Technologies
Beckman Coulter
Roche
Qiagen
Luminex Corporation
Enzo Life Sciences
Bio-rad
Sequenom
Ocimum Biosolutions
GE Healthcare
GenScript
Douglas Scientific
BGI
Beijing Sunbiotech
HuaGene Biotech
Generay Biotech
Benegene
Shanghai Biochip
GENESKY
HD Biosciences
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Single Nucleotide Polymorphism (SNP) Genotyping Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Single Nucleotide Polymorphism (SNP) Genotyping Overall Market Size
2.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size: 2021 VS 2027
2.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Single Nucleotide Polymorphism (SNP) Genotyping Players in Global Market
3.2 Top Global Single Nucleotide Polymorphism (SNP) Genotyping Companies Ranked by Revenue
3.3 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Companies
3.4 Top 3 and Top 5 Single Nucleotide Polymorphism (SNP) Genotyping Companies in Global Market, by Revenue in 2020
3.5 Global Companies Single Nucleotide Polymorphism (SNP) Genotyping Product Type
3.6 Tier 1, Tier 2 and Tier 3 Single Nucleotide Polymorphism (SNP) Genotyping Players in Global Market
3.6.1 List of Global Tier 1 Single Nucleotide Polymorphism (SNP) Genotyping Companies
3.6.2 List of Global Tier 2 and Tier 3 Single Nucleotide Polymorphism (SNP) Genotyping Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Markets, 2021 & 2027
4.1.2 Transversion
4.1.3 Transition
4.2 By Type - Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue & Forecasts
4.2.1 By Type - Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue, 2016-2021
4.2.2 By Type - Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue, 2022-2027
4.2.3 By Type - Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size, 2021 & 2027
5.1.2 Diagnostics
5.1.3 Animal
5.1.4 Plant
5.1.5 Research
5.1.6 Others
5.2 By Application - Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue & Forecasts
5.2.1 By Application - Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue, 2016-2021
5.2.2 By Application - Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue, 2022-2027
5.2.3 By Application - Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size, 2021 & 2027
6.2 By Region - Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue & Forecasts
6.2.1 By Region - Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue, 2016-2021
6.2.2 By Region - Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue, 2022-2027
6.2.3 By Region - Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Single Nucleotide Polymorphism (SNP) Genotyping Revenue, 2016-2027
6.3.2 US Single Nucleotide Polymorphism (SNP) Genotyping Market Size, 2016-2027
6.3.3 Canada Single Nucleotide Polymorphism (SNP) Genotyping Market Size, 2016-2027
6.3.4 Mexico Single Nucleotide Polymorphism (SNP) Genotyping Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Single Nucleotide Polymorphism (SNP) Genotyping Revenue, 2016-2027
6.4.2 Germany Single Nucleotide Polymorphism (SNP) Genotyping Market Size, 2016-2027
6.4.3 France Single Nucleotide Polymorphism (SNP) Genotyping Market Size, 2016-2027
6.4.4 U.K. Single Nucleotide Polymorphism (SNP) Genotyping Market Size, 2016-2027
6.4.5 Italy Single Nucleotide Polymorphism (SNP) Genotyping Market Size, 2016-2027
6.4.6 Russia Single Nucleotide Polymorphism (SNP) Genotyping Market Size, 2016-2027
6.4.7 Nordic Countries Single Nucleotide Polymorphism (SNP) Genotyping Market Size, 2016-2027
6.4.8 Benelux Single Nucleotide Polymorphism (SNP) Genotyping Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Single Nucleotide Polymorphism (SNP) Genotyping Revenue, 2016-2027
6.5.2 China Single Nucleotide Polymorphism (SNP) Genotyping Market Size, 2016-2027
6.5.3 Japan Single Nucleotide Polymorphism (SNP) Genotyping Market Size, 2016-2027
6.5.4 South Korea Single Nucleotide Polymorphism (SNP) Genotyping Market Size, 2016-2027
6.5.5 Southeast Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Size, 2016-2027
6.5.6 India Single Nucleotide Polymorphism (SNP) Genotyping Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Single Nucleotide Polymorphism (SNP) Genotyping Revenue, 2016-2027
6.6.2 Brazil Single Nucleotide Polymorphism (SNP) Genotyping Market Size, 2016-2027
6.6.3 Argentina Single Nucleotide Polymorphism (SNP) Genotyping Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Revenue, 2016-2027
6.7.2 Turkey Single Nucleotide Polymorphism (SNP) Genotyping Market Size, 2016-2027
6.7.3 Israel Single Nucleotide Polymorphism (SNP) Genotyping Market Size, 2016-2027
6.7.4 Saudi Arabia Single Nucleotide Polymorphism (SNP) Genotyping Market Size, 2016-2027
6.7.5 UAE Single Nucleotide Polymorphism (SNP) Genotyping Market Size, 2016-2027
7 Players Profiles
7.1 Illumina
7.1.1 Illumina Corporate Summary
7.1.2 Illumina Business Overview
7.1.3 Illumina Single Nucleotide Polymorphism (SNP) Genotyping Major Product Offerings
7.1.4 Illumina Single Nucleotide Polymorphism (SNP) Genotyping Revenue in Global (2016-2021)
7.1.5 Illumina Key News
7.2 Affymetrix
7.2.1 Affymetrix Corporate Summary
7.2.2 Affymetrix Business Overview
7.2.3 Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Major Product Offerings
7.2.4 Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Revenue in Global (2016-2021)
7.2.5 Affymetrix Key News
7.3 Applied Biosystems
7.3.1 Applied Biosystems Corporate Summary
7.3.2 Applied Biosystems Business Overview
7.3.3 Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Major Product Offerings
7.3.4 Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Revenue in Global (2016-2021)
7.3.5 Applied Biosystems Key News
7.4 Agilent Technologies
7.4.1 Agilent Technologies Corporate Summary
7.4.2 Agilent Technologies Business Overview
7.4.3 Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Major Product Offerings
7.4.4 Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Revenue in Global (2016-2021)
7.4.5 Agilent Technologies Key News
7.5 Beckman Coulter
7.5.1 Beckman Coulter Corporate Summary
7.5.2 Beckman Coulter Business Overview
7.5.3 Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Major Product Offerings
7.5.4 Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Revenue in Global (2016-2021)
7.5.5 Beckman Coulter Key News
7.6 Roche
7.6.1 Roche Corporate Summary
7.6.2 Roche Business Overview
7.6.3 Roche Single Nucleotide Polymorphism (SNP) Genotyping Major Product Offerings
7.6.4 Roche Single Nucleotide Polymorphism (SNP) Genotyping Revenue in Global (2016-2021)
7.6.5 Roche Key News
7.7 Qiagen
7.7.1 Qiagen Corporate Summary
7.7.2 Qiagen Business Overview
7.7.3 Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Major Product Offerings
7.4.4 Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Revenue in Global (2016-2021)
7.7.5 Qiagen Key News
7.8 Luminex Corporation
7.8.1 Luminex Corporation Corporate Summary
7.8.2 Luminex Corporation Business Overview
7.8.3 Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Major Product Offerings
7.8.4 Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Revenue in Global (2016-2021)
7.8.5 Luminex Corporation Key News
7.9 Enzo Life Sciences
7.9.1 Enzo Life Sciences Corporate Summary
7.9.2 Enzo Life Sciences Business Overview
7.9.3 Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Major Product Offerings
7.9.4 Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Revenue in Global (2016-2021)
7.9.5 Enzo Life Sciences Key News
7.10 Bio-rad
7.10.1 Bio-rad Corporate Summary
7.10.2 Bio-rad Business Overview
7.10.3 Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Major Product Offerings
7.10.4 Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Revenue in Global (2016-2021)
7.10.5 Bio-rad Key News
7.11 Sequenom
7.11.1 Sequenom Corporate Summary
7.11.2 Sequenom Business Overview
7.11.3 Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Major Product Offerings
7.11.4 Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Revenue in Global (2016-2021)
7.11.5 Sequenom Key News
7.12 Ocimum Biosolutions
7.12.1 Ocimum Biosolutions Corporate Summary
7.12.2 Ocimum Biosolutions Business Overview
7.12.3 Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Major Product Offerings
7.12.4 Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Revenue in Global (2016-2021)
7.12.5 Ocimum Biosolutions Key News
7.13 GE Healthcare
7.13.1 GE Healthcare Corporate Summary
7.13.2 GE Healthcare Business Overview
7.13.3 GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Major Product Offerings
7.13.4 GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Revenue in Global (2016-2021)
7.13.5 GE Healthcare Key News
7.14 GenScript
7.14.1 GenScript Corporate Summary
7.14.2 GenScript Business Overview
7.14.3 GenScript Single Nucleotide Polymorphism (SNP) Genotyping Major Product Offerings
7.14.4 GenScript Single Nucleotide Polymorphism (SNP) Genotyping Revenue in Global (2016-2021)
7.14.5 GenScript Key News
7.15 Douglas Scientific
7.15.1 Douglas Scientific Corporate Summary
7.15.2 Douglas Scientific Business Overview
7.15.3 Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Major Product Offerings
7.15.4 Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Revenue in Global (2016-2021)
7.15.5 Douglas Scientific Key News
7.16 BGI
7.16.1 BGI Corporate Summary
7.16.2 BGI Business Overview
7.16.3 BGI Single Nucleotide Polymorphism (SNP) Genotyping Major Product Offerings
7.16.4 BGI Single Nucleotide Polymorphism (SNP) Genotyping Revenue in Global (2016-2021)
7.16.5 BGI Key News
7.17 Beijing Sunbiotech
7.17.1 Beijing Sunbiotech Corporate Summary
7.17.2 Beijing Sunbiotech Business Overview
7.17.3 Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Major Product Offerings
7.17.4 Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue in Global (2016-2021)
7.17.5 Beijing Sunbiotech Key News
7.18 HuaGene Biotech
7.18.1 HuaGene Biotech Corporate Summary
7.18.2 HuaGene Biotech Business Overview
7.18.3 HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Major Product Offerings
7.18.4 HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue in Global (2016-2021)
7.18.5 HuaGene Biotech Key News
7.19 Generay Biotech
7.19.1 Generay Biotech Corporate Summary
7.19.2 Generay Biotech Business Overview
7.19.3 Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Major Product Offerings
7.19.4 Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue in Global (2016-2021)
7.19.5 Generay Biotech Key News
7.20 Benegene
7.20.1 Benegene Corporate Summary
7.20.2 Benegene Business Overview
7.20.3 Benegene Single Nucleotide Polymorphism (SNP) Genotyping Major Product Offerings
7.20.4 Benegene Single Nucleotide Polymorphism (SNP) Genotyping Revenue in Global (2016-2021)
7.20.5 Benegene Key News
7.21 Shanghai Biochip
7.21.1 Shanghai Biochip Corporate Summary
7.21.2 Shanghai Biochip Business Overview
7.21.3 Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Major Product Offerings
7.21.4 Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Revenue in Global (2016-2021)
7.21.5 Shanghai Biochip Key News
7.22 GENESKY
7.22.1 GENESKY Corporate Summary
7.22.2 GENESKY Business Overview
7.22.3 GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Major Product Offerings
7.22.4 GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Revenue in Global (2016-2021)
7.22.5 GENESKY Key News
7.23 HD Biosciences
7.23.1 HD Biosciences Corporate Summary
7.23.2 HD Biosciences Business Overview
7.23.3 HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Major Product Offerings
7.23.4 HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Revenue in Global (2016-2021)
7.23.5 HD Biosciences Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Single Nucleotide Polymorphism (SNP) Genotyping Market Opportunities & Trends in Global Market
Table 2. Single Nucleotide Polymorphism (SNP) Genotyping Market Drivers in Global Market
Table 3. Single Nucleotide Polymorphism (SNP) Genotyping Market Restraints in Global Market
Table 4. Key Players of Single Nucleotide Polymorphism (SNP) Genotyping in Global Market
Table 5. Top Single Nucleotide Polymorphism (SNP) Genotyping Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Share by Companies, 2016-2021
Table 8. Global Companies Single Nucleotide Polymorphism (SNP) Genotyping Product Type
Table 9. List of Global Tier 1 Single Nucleotide Polymorphism (SNP) Genotyping Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Single Nucleotide Polymorphism (SNP) Genotyping Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type
Illumina
Affymetrix
Applied Biosystems
Agilent Technologies
Beckman Coulter
Roche
Qiagen
Luminex Corporation
Enzo Life Sciences
Bio-rad
Sequenom
Ocimum Biosolutions
GE Healthcare
GenScript
Douglas Scientific
BGI
Beijing Sunbiotech
HuaGene Biotech
Generay Biotech
Benegene
Shanghai Biochip
GENESKY
HD Biosciences